Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/12911
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2023-03-01T15:44:38Z-
dc.date.available2023-03-01T15:44:38Z-
dc.date.issued2022-11-
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/12911-
dc.publisherINCApt_BR
dc.subjectServiço de Farmácia Hospitalar/tendênciaspt_BR
dc.subjectPharmacy Service, Hospital/trendspt_BR
dc.subjectServicio de Farmacia en Hospital/tendenciaspt_BR
dc.subjectCongressopt_BR
dc.subjectCongresspt_BR
dc.subjectCongresopt_BR
dc.subjectDias, Claudia de Oliveira Passospt_BR
dc.subjectAntineoplásicospt_BR
dc.subjectAssistência Farmacêuticapt_BR
dc.subjectPharmaceutical Servicespt_BR
dc.subjectServicios Farmacéuticospt_BR
dc.titleCongresso debate os desafios da farmácia oncológicapt_BR
dc.title.alternativeInforme INCA 425pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe Inca 425

Files in This Item:
File Description SizeFormat 
Informe-INCA-2022-425-4-Congresso-debate-os.pdf298.01 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.